Design and synthesis of new potent anticancer pyrazoles with high FLT3 kinase inhibitory selectivity
Authors:
- Ibrahim Mustafa El-DeebIEIbrahim Mustafa El-Deeb
- So Ha LeeSLSo Ha Lee
- 1 June 2010
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (11) , 3961-3973
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Design, synthesis, screening, and molecular modeling study of a new series of ROS1 receptor tyrosine kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2009
- Potent and selective pyrazole-based inhibitors of B-Raf kinaseBioorganic & Medicinal Chemistry Letters, 2008
- Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanonesBioorganic & Medicinal Chemistry, 2007
- Metathesis Reactions of Pyrazolotriazinones Generate Dynamic Combinatorial LibrariesOrganic Letters, 2005
- Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and KitBioorganic & Medicinal Chemistry, 2003
- Oncogenic kinase signallingNature, 2001
- Synthesis of Benzo[b]phenanthridines and Related Naturally Occurring 2-Aryl-1,4-naphthoquinones by Palladium- and Copper-Catalyzed Coupling of Organostannanes with BromoquinonesEuropean Journal of Organic Chemistry, 2001
- Protein–protein interactions define specificity in signal transductionGenes & Development, 2000
- Signaling—2000 and BeyondCell, 2000
- Synthesis of Reserpine Analogs1,2The Journal of Organic Chemistry, 1959